Neuropeptide Y receptor Y5 and nucleic acid sequences
AssigneeBayer Aktiengesellschaft
InventorsYinghe Hu, Michael L. McCaleb, Brian T. Bloomquist, Jaime R. Flores-Riveros, Linda J. Cornfield
Life of this patent
Estimating the term…
Loading patent…
AssigneeBayer Aktiengesellschaft
InventorsYinghe Hu, Michael L. McCaleb, Brian T. Bloomquist, Jaime R. Flores-Riveros, Linda J. Cornfield
Estimating the term…
The present invention provides novel NPY/PYY receptor proteins and nucleic acid sequence encoding them. The invention is directed to the isolation, characterization, and pharmacological use of these receptors and nucleic acids. In particular, this invention provides human and rat NPY/PYY receptors (which we call the NPY Y5 receptor) and nucleic acids. Also provided are recombinant expression constructs useful for transfecting cells and expressing the protein in vitro and in vivo. The invention further provides methods for detecting expression levels of the protein as well as methods for screening for receptor antagonists and agonists to be used for the treatment of obesity or anorexia, respectively.
An isolated nucleic acid encoding a polypeptide consisting of an amino acid sequence as set forth in SEQ ID NO:
An isolated nucleic acid encoding a polypeptide consisting of an amino acid sequence as set forth in SEQ ID NO:
Dependencies are inferred from the claim text.